Vitreoretinal Surgery Device Market Product Trends, Key Companies, Revenue Share Analysis by Fact MR

The global vitreoretinal surgery device market is estimated to be valued at USD 2.23 billion in 2024, and it is expected to grow at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2034. By the end of 2034, the demand for vitreoretinal surgery devices is projected to reach a market value of USD 4.01 billion. The vitreoretinal surgery device market is developing at a considerable growth rate, which can be attributed majorly to the rising cases of retinal diseases, advanced innovations in surgical procedures, and the emerging acceptance of minimally invasive procedures. The devices are major equipment ophthalmologists use in rendering delicate surgeries on the retina and vitreous humor of the eye. Devices involved in this category range from vitrectomy machines to illumination devices, laser systems, and retinal surgical instruments.

Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=10215

Market Drivers

Rising Burden of Retinal Diseases

The rising burden of retinal diseases, such as diabetic retinopathy, macular degeneration, and retinal detachment, is one of the major factors promoting the growth in demand for vitreoretinal surgery devices. According to the World Health Organization, nearly one-third of patients suffering from diabetes are affected by diabetic retinopathy, which is a condition that calls for effective surgical interventions with the highest degree of urgency.

Improvements in Surgical Techniques

Advances in technology have made vitreoretinal surgeries much more safe and effective. It has introduced innovations or adaptations of the 3D visualization system, micro-incision vitrectomy surgery, and advanced fluidics systems, which have brought about a sea change as far as retinal surgeries are concerned since they have been done with enhanced precision and result in better outcomes. This is encouraging more and more ophthalmologists to adopt vitreoretinal surgery devices with these kinds of advancements.

Growing Adoption of Minimally Invasive Techniques

The other key driver of market growth is the trend toward minimally invasive surgeries. Indeed, minimally invasive vitreoretinal surgery brings with it the clear advantages of less trauma to the patient, a shorter recovery period, and fewer complications. Thus, these procedures come increasingly in demand by patients and healthcare providers, which in turn stimulates demand for better and more advanced vitreoretinal surgery devices.

Regional Analysis

North America

North America holds quite a decent share of the vitreoretinal surgery devices market due to the prevalence of retinal diseases and well-developed healthcare infrastructure, coupled with key players in the region. The major market growth in this region was by the United States, since it has advanced medical facilities and high expenditure towards healthcare.

Europe

Another key market for vitreoretinal surgery devices is Europe, where the growth is being fueled by factors such as an increase in the geriatric population and the subsequent rise in the prevalence of age-related macular degeneration. Other driving factors include government initiatives to enhance eye care services that are helping expand the market.

Asia-Pacific:

It is expected that, out of all the geographical areas, the Asia Pacific region will have the fastest growth rate in this market during the forecast period. Some major factors, such as increasing prevalence for diabetes, betterment of health infrastructure, and rise in awareness regarding retinal diseases, will boost the growth of this market. Countries such as China and India are important future growth markets for vitreoretinal surgery devices due to the presence of large patient pools and developing healthcare sectors.

Latin America and Middle East & Africa

These regions are also growing in the vitreoretinal surgery device market; it is slow as compared to other regions. The rising adoption of advanced surgical techniques and improving healthcare facilities bring fuel to the market growth in these regions.

Key Players in the Market

Hoya Surgical Optics

Rodenstock

Topcon Corporation

Alcon Inc.

Cooper Vision

British Virgin Islands (BVI)

Johnson & Johnson Vision Care, Inc.

Erbe Elektromedizin

Safilo Group

Carl Zeiss Meditec AG

Blink Medical

Nidek Co. Ltd.

Future Outlook

The future of vitreoretinal surgery devices appears bright, with continued technological developments and growing awareness about retinal diseases. Additionally, the growing adoption of telemedicine and remote monitoring systems is expected to turn into major growth drivers. Furthermore, developing cost-effective surgical devices and expansion of healthcare services in emerging economies will further open up opportunities for market players.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=10215

Competitive Landscape

Key players in the vitreoretinal surgery device market are concentrating on introducing innovative techniques to treat retinal detachments and expanding the application of vitrectomy. The technological advantages of these products stand out as significant differentiators in the market.

In December 2023, Carl Zeiss Meditec announced its acquisition of the Dutch Ophthalmic Research Center to broaden its range of ophthalmic devices. This acquisition, valued at approximately USD 1.07 billion and expected to be completed in 2024, aims to enhance Zeiss's inventory of vitreoretinal surgical instruments.

In June 2022, Ellex Medical Lasers launched the EYESYS 23G Vitrectomy technology, a new minimally invasive technology designed to provide surgeons with a more precise and efficient method for performing vitreoretinal surgeries.

In May 2022, Alcon introduced the Constellation Vision System, a next-generation vitreoretinal surgical platform. This system features several technical advancements, including improved visualization and more precise instrumentation, enhancing the capabilities of vitreoretinal surgical procedures.

About Fact.MR : 

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com